Skip to main content
Home / Recent Patents on CNS Drug Discovery (Discontinued), Volume 5, Number 3
Recent Patents on CNS Drug Discovery publishes review articles on recent patents in the field of CNS drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on CNS drug discovery is also included in the journal. The journal is essential reading for all researchers involved in CNS drug design and discovery.

Publisher: Bentham Science Publishers

Volume 5, Number 3, 2010

Articles

Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders
pp. 182-194(13)
Authors: Siotto, Mariacristina; Bucossi, Serena; Squitti, Rosanna

Favourites:
ADD

Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases
pp. 195-202(8)
Authors: Martin, Antonio; De Vivo, Giulia; Ricotta, Mariangela; Iannuzzi, Maura; Gentile, Vittorio

Favourites:
ADD

Current Options in the Treatment of Mitochondrial Diseases
pp. 203-209(7)
Authors: Scarpelli, Mauro; Sofia Cotelli, Maria; Mancuso, Michelangelo; Tomelleri, Giuliano; Tonin, Paola; Baronchelli, Carla; Vielmi, Valentina; Gregorelli, Valeria; Todeschini, Alice; Padovani, Alessandro; Filosto, Massimiliano

Favourites:
ADD

PTI-609: A Novel Analgesic that Binds Filamin A to Control Opioid Signaling
pp. 210-220(11)
Authors: H. Burns, Lindsay; Wang, Hoau-Yan

Favourites:
ADD

Pharmacological Therapy of Parkinson's Disease: Current Options and New Avenues
pp. 221-238(18)
Authors: Simola, Nicola; Pinna, Annalisa; Fenu, Sandro

Favourites:
ADD

On the Future Development of Optimally-Sized Lipid-Insoluble Systemic Therapies for CNS Solid Tumors and Other Neuropathologies
pp. 239-252(14)
Author: Sarin, Hemant

Favourites:
ADD

Neurogenic Drugs and Compounds
pp. 253-257(5)
Author: Taupin, Philippe

Favourites:
ADD

Patent Selections:
pp. 258-261(4)
Author: Bentham Science Publishers

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content